Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes is a research paper published in Ophthalmology Science (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Science and Technology Commission of Shanghai Municipality
Grant: 23Y11901300
Science and Technology Commission of Shanghai Municipality
Grant: 23J41900200
National Institutes of Health
Grant: R01 EY030564
National Institutes of Health
Grant: R01 EY028753
National Institutes of Health
Grant: R01AG060942
National Institutes of Health
Grant: 282,905
National Institutes of Health
Grant: 759,544
National Institutes of Health
Grant: 354,378
Ministry of Education of the People's Republic of China
Grant: TM202115PT
National Natural Science Foundation of China
Grant: 82171076
National Natural Science Foundation of China
Grant: 82388101
National Natural Science Foundation of China
Grant: U22A20311
National Key Research and Development Program of China
Grant: 2022YFC2502800
BioCryst
Boehringer Ingelheim
Ministry of Science and Technology of the People's Republic of China
Research and Innovation in Science and Technology Project
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
Keywords